143 related articles for article (PubMed ID: 31439295)
1. MRI Safety for Patients Implanted With the MRI Ready ICD System: MRI Ready Study Results.
Nazarian S; Cantillon DJ; Woodard PK; Mela T; Cline AM; Strickberger AS;
JACC Clin Electrophysiol; 2019 Aug; 5(8):935-943. PubMed ID: 31439295
[TBL] [Abstract][Full Text] [Related]
2. Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study.
Gold MR; Sommer T; Schwitter J; Al Fagih A; Albert T; Merkely B; Peterson M; Ciuffo A; Lee S; Landborg L; Cerkvenik J; Kanal E;
J Am Coll Cardiol; 2015 Jun; 65(24):2581-2588. PubMed ID: 25982014
[TBL] [Abstract][Full Text] [Related]
3. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
Awad K; Griffin J; Crawford TC; Lane Cox S; Ferrick K; Mazur A; Pena RE; Lloyd SG; Michalski J; Johnson W; Bailey WM
Heart Rhythm; 2015 Oct; 12(10):2155-61. PubMed ID: 26049048
[TBL] [Abstract][Full Text] [Related]
4. Clinical safety of an MRI conditional implantable cardioverter defibrillator system: A prospective Monocenter ICD-Magnetic resonance Imaging feasibility study (MIMI).
Kypta A; Blessberger H; Hoenig S; Saleh K; Lambert T; Kammler J; Fellner F; Lichtenauer M; Steinwender C
J Magn Reson Imaging; 2016 Mar; 43(3):574-84. PubMed ID: 26335332
[TBL] [Abstract][Full Text] [Related]
5. Safety of magnetic resonance imaging scanning in patients with cardiac resynchronization therapy-defibrillators incorporating quadripolar left ventricular leads.
Rinaldi CA; Vitoff PJ; Nair DG; Bernstein R; Mountantonakis SE; Rapacciuolo A; Carter N; Tse HF; Green UB
Heart Rhythm; 2020 Dec; 17(12):2064-2071. PubMed ID: 32911050
[TBL] [Abstract][Full Text] [Related]
6. Clinical safety of the ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 3 T: results of the ProMRI 3T ENHANCED Master study.
Zbinden R; Wollmann C; Brachmann J; Michaelsen J; Steinwender C; Kovoor P; Kelle S; McGavigan AD; Ching CK; Figtree GA; Schmidt J; Timmel T; Lotz J
Europace; 2019 Nov; 21(11):1678-1685. PubMed ID: 31322701
[TBL] [Abstract][Full Text] [Related]
7. Clinical safety and performance of a MRI conditional pacing system in patients undergoing cardiac MRI.
Ching CK; Chakraborty RN; Kler TS; Pumprueg S; Ngarmukos T; Chan JYS; Anand S; Yadav R; Sitthisook S; Yim KW; Jaswal RK; Bhargava K
Pacing Clin Electrophysiol; 2017 Dec; 40(12):1389-1395. PubMed ID: 29090491
[TBL] [Abstract][Full Text] [Related]
8. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
9. Impact of magnetic resonance imaging on ventricular tachyarrhythmia sensing: Results of the Evera MRI Study.
Gold MR; Sommer T; Schwitter J; Kanal E; Bernabei MA; Love CJ; Surber R; Ramza B; Cerkvenik J; Merkely B
Heart Rhythm; 2016 Aug; 13(8):1631-5. PubMed ID: 27196818
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of implantable cardioverter-defibrillator developed for magnetic resonance imaging use.
Gold MR; Kanal E; Schwitter J; Sommer T; Yoon H; Ellingson M; Landborg L; Bratten T
Heart Rhythm; 2015 Mar; 12(3):631-638. PubMed ID: 25496984
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.
Burke MC; Gold MR; Knight BP; Barr CS; Theuns DAMJ; Boersma LVA; Knops RE; Weiss R; Leon AR; Herre JM; Husby M; Stein KM; Lambiase PD
J Am Coll Cardiol; 2015 Apr; 65(16):1605-1615. PubMed ID: 25908064
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficiency of low-field magnetic resonance imaging in patients with cardiac rhythm management devices.
Schukro C; Puchner SB
Eur J Radiol; 2019 Sep; 118():96-100. PubMed ID: 31439265
[TBL] [Abstract][Full Text] [Related]
13. Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla.
Bauer WR; Lau DH; Wollmann C; McGavigan A; Mansourati J; Reiter T; Frömer S; Ladd ME; Quick HH
Sci Rep; 2019 Dec; 9(1):18243. PubMed ID: 31796767
[TBL] [Abstract][Full Text] [Related]
14. Image Quality of Cardiac Magnetic Resonance Imaging in Patients With an Implantable Cardioverter Defibrillator System Designed for the Magnetic Resonance Imaging Environment.
Schwitter J; Gold MR; Al Fagih A; Lee S; Peterson M; Ciuffo A; Zhang Y; Kristiansen N; Kanal E; Sommer T;
Circ Cardiovasc Imaging; 2016 May; 9(5):. PubMed ID: 27151268
[TBL] [Abstract][Full Text] [Related]
15. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging in patients with a subcutaneous implantable cardioverter-defibrillator.
Keller J; Neužil P; Vymazal J; Janotka M; Brada J; Žáček R; Vopálka R; Weichet J; Reddy VY
Europace; 2015 May; 17(5):761-6. PubMed ID: 25687749
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.
Zareba W; Daubert JP; Beck CA; Huang DT; Alexis JD; Brown MW; Pyykkonen K; McNitt S; Oakes D; Feng C; Aktas MK; Ayala-Parades F; Baranchuk A; Dubuc M; Haigney M; Mazur A; McPherson CA; Mitchell LB; Natale A; Piccini JP; Raitt M; Rashtian MY; Schuger C; Winters S; Worley SJ; Ziv O; Moss AJ;
J Am Coll Cardiol; 2018 Aug; 72(6):636-645. PubMed ID: 30071993
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
Guerra F; Palmisano P; Dell'Era G; Ziacchi M; Ammendola E; Bonelli P; Patani F; Cupido C; Devecchi C; Accogli M; Occhetta E; Santangelo L; Biffi M; Boriani G; Capucci A;
Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Imaging in Patients With Cardiac Implantable Electronic Devices With Abandoned Leads.
Schaller RD; Brunker T; Riley MP; Marchlinski FE; Nazarian S; Litt H
JAMA Cardiol; 2021 May; 6(5):549-556. PubMed ID: 33595595
[TBL] [Abstract][Full Text] [Related]
20. Safe performance of magnetic resonance imaging on a patient with an ICD.
Wollmann C; Grude M; Tombach B; Kugel H; Heindel W; Breithardt G; Böcker D; Vahlhaus C
Pacing Clin Electrophysiol; 2005 Apr; 28(4):339-42. PubMed ID: 15826273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
